Despite the executive order signed by Donald Trump, cannabis continues without federal legalization in the US, keeping the market dependent on state laws

Organization states funding initiatives aiming to extinguish the adult-use market in both U.S. states

While the US seeks to include medicinal cannabis in insurance coverage, Brazil advances through state laws and judicial decisions for access to treatment

The search for relief from chronic pain and sleep disorders reveals a cultural and therapeutic shift among the elderly

President advances in the medicinal agenda and targets elderly electorate with CBD in Medicare, but signs law that threatens hemp market

Trump states he does not intend to use medical cannabis, but acknowledges that the substance can be an alternative to opioids and necessary for many patients

Moving from Schedule I to Schedule III could unlock research, ease tax hurdles, and impact state markets

Technology inspired by fungi promises cultivated and sustainable chips

Proposal redefining limits and banning derivatives with total THC advances in the Senate with White House support

Organizations are pressuring President Trump to legalize marijuana in the US, going beyond mere rescheduling and seeking to repair the damages of historical prohibition

Experts point out that federal legalization could open doors for national trademarks, but obstacles still persist

Habit of consuming cannabis during the "Cousin's Walk" stops being a family secret and becomes the focus of media and commerce in the USA

The Australian medicinal cannabis market is consolidating as an international reference and inspiring discussions in Brazil

The US Department of Defense will start testing military personnel for psilocybin, a psychedelic substance found in mushrooms, aiming at the safety, discipline, and readiness of the armed forces

The Trump administration is considering reclassifying marijuana as a lower-risk drug, a move that would facilitate research, investments, and tax deductions for the sector

Federal reclassification drives mergers and acquisitions in the US cannabis sector

Large-scale study funded by the US government reveals that older adults who use cannabis have superior brain performance and possible neuroprotective benefits

Proposal announced by Democrats envisions adult and medicinal use of cannabis, as well as the creation of a regulatory body in the state

State data shows monthly fluctuations and annual sales volume decline

American measure rendering full spectrum extracts unfeasible has a long transition period, but already positions Uruguay as a new strategic export alternative